HOME › DRUGS › ANAGRELIDE
ACTIVE SUBSTANCE / INN

ANAGRELIDE

Brand name(s): Anagrelide Viatris (previously Anagrelide Mylan), Xagrid
EMA LISTED
AUTHORISED
Thrombocythemia, Essential
ACTIVE SUBSTANCE
Anagrelide
REGULATORS
EMA
SPONSORS / MAH
Viatris Limited, Takeda Pharmaceuticals International AG Ireland
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Anagrelide Viatris (previously Anagrelide Mylan)Viatris LimitedAuthorised15/02/2018Thrombocythemia, Essential
XagridTakeda Pharmaceuticals International AG IrelandAuthorised15/11/2004Thrombocythemia, Essential

FULL INTELLIGENCE ON ANAGRELIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →